Nomura Holdings Formalizes Delaware Management Company as Specified Subsidiary
NMR sits 88% above its 52-week low of $4.86 on elevated volume (2.8× avg).
Summary
Nomura Holdings announced that Delaware Management Company (DMC), acquired as part of Macquarie's asset management business, has formally become a "specified subsidiary," with its results to be consolidated from Q3 FY2026.
Key Events · M&A and Partnerships · NMR
-
Delaware Management Company Becomes Specified Subsidiary
Delaware Management Company (DMC) has formally been designated a "specified subsidiary" of Nomura Holdings, effective December 1, 2025.
-
Follows Prior Acquisition
This designation is a result of Nomura's completed acquisition of Macquarie Group Limited's U.S. and European public asset management business, previously announced on April 22, 2025, and December 1, 2025.
-
Significant Capital Contribution
DMC's share capital of USD 590 million represents a material portion of Nomura's capital, triggering the "specified subsidiary" status.
-
Financial Consolidation Impact
DMC's consolidated operating results and financial position will be reflected in Nomura's consolidated results starting from the third quarter of the fiscal year ending March 2026.
Analysis · NMR · Finance
This filing formalizes the status of Delaware Management Company (DMC) as a "specified subsidiary" of Nomura Holdings, following the completion of the acquisition of Macquarie Group Limited's U.S. and European public asset management business. The designation is due to DMC's share capital of USD 590 million exceeding 10% of Nomura's capital. This update confirms the integration of a significant asset management entity, with DMC's consolidated results set to be reflected in Nomura's financial statements starting from the third quarter of the fiscal year ending March 2026. This is a key step in the operational and financial integration of the previously announced acquisition.
At the time of this filing, NMR was trading at $9.14 on NYSE in the Finance sector, with a market capitalization of approximately $27.4B. The 52-week trading range was $4.86 to $9.47. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.